MICHAEL BRAUN to Antineoplastic Agents
This is a "connection" page, showing publications MICHAEL BRAUN has written about Antineoplastic Agents.
Connection Strength
0.025
-
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer. Eur J Cancer. 2014 Dec; 50(18):3136-44.
Score: 0.025
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.